Copeptin is associated with mortality in elderly people

Area of Science:

• Cardiology
• Biomarkers
• Prognostic Indicators

Background:

• Elevated copeptin, a marker of vasopressin release, is linked to poor prognosis in acute myocardial infarction (MI).
• The prognostic significance of copeptin beyond the acute MI phase requires further investigation.
• The relationship between copeptin, stress markers (cortisol), and heart failure markers (NTproBNP) needs clarification.

Purpose of the Study:

• To determine if elevated copeptin levels predict long-term prognosis after MI.
• To assess the association between copeptin and markers of stress and heart failure.
• To investigate the independent prognostic value of copeptin in relation to other clinical factors.

Main Methods:

• Copeptin, cortisol, and NTproBNP levels were measured in 926 participants of the ICELAND MI study.
• Participants included those with and without previous MI, identified via cardiac magnetic resonance imaging.
• Cox proportional hazard regression models were used to assess the association between copeptin and cardiovascular events, total mortality, heart failure, and MI.

Main Results:

• Copeptin levels were significantly higher in participants with previous MI compared to those without.
• Increased copeptin showed a weak correlation with evening cortisol and NTproBNP.
• Copeptin remained independently associated with total mortality after adjusting for multiple clinical factors, including cortisol and NTproBNP.

Conclusions:

• Copeptin levels are elevated in individuals with prior MI, irrespective of recognition status.
• The prognostic implications of copeptin extend beyond heart failure and stress pathways.
• Copeptin serves as an independent predictor of total mortality, indicating general vulnerability.